Our lab uses next generation sequencing technologies to investigate genetic and molecular alterations associated with skin cancer and skin diseases. Using genetic and molecular data obtained from patients, we predict and develop new therapeutics for a variety of skin disorders. Our ultimate goal is to utilize molecular information to manage and treat patients with dermatologic disorders.
Skin CANCER RISK
We employ big data analyses and next generation sequencing technologies to identify genetic alterations associated with susceptibility to skin cancer. This information helps identify new pathways involved in skin cancer development and identify new biomarkers to identify individuals at risk of skin cancer.
Using genomic and transcriptomic sequencing, we investigate genetic alterations associated with skin cancer initiation, progression, and response to treatment.
We utilize molecular and genetic data from tumors to predict new therapeutics for skin cancers and other skin diseases. We conduct clinical trials to test predicted therapeutics.